close
Investment
4 mins to read

AFT ‘honestly wouldn’t entertain’ raise to outright purchase IP

The pharmaceutical company remains confident in its own business model, as it mulls how much to pay out in dividends this year.

AFT Pharmaceuticals co-founder and managing director Hartley Atkinson.

Kate McVicar Thu, 23 Nov 2023
Key points
  • Revenue: Up 27% to $84m.
  • Profit: Up 17% to $1.8m. 
  • Main takeaway: The company does not want to follow in the shoes of others by raising capital to fully purchase new assets. It is confident in its growth pipeline of diverse products. 

AFT Pharmaceuticals is satisfied with its approach to innovation and product development and wouldn’t consider capital raising to outright purchase new intellectual property.

During AFT’s interim investor call, co-founder and chief executive Hartley Atkinson made reference to a Singaporean

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Kate McVicar Thu, 23 Nov 2023
Contact the Writer: kate@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Key points
  • Revenue: Up 27% to $84m.
  • Profit: Up 17% to $1.8m. 
  • Main takeaway: The company does not want to follow in the shoes of others by raising capital to fully purchase new assets. It is confident in its growth pipeline of diverse products. 
Company profile
Powered by:
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
AFT ‘honestly wouldn’t entertain’ raise to outright purchase IP
Investment,
101819